Stockreport

Travere Therapeutics Reports Second Quarter 2022 Financial Results

Travere Therapeutics, Inc.  (TVTX) 
PDF SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its second quarter 2022 financial results and provided a corporat [Read more]